Literature DB >> 15948927

Better medicines for children--where are we now, and where do we want to be?

Klaus Rose1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948927      PMCID: PMC1884858          DOI: 10.1111/j.1365-2125.2005.02411.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Testing new drugs in naked apes and getting the dose right in their young.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

2.  The EU-regulation on medicinal products for paediatric use: impacts on child and adolescent psychiatry and clinical research with minors.

Authors:  Michael Kölch; Kathlen Schnoor; Jörg M Fegert
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-04-07       Impact factor: 4.785

3.  Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?

Authors:  Anne E M Brabers; Ellen H M Moors; Sonja van Weely; Remco L A de Vrueh
Journal:  Orphanet J Rare Dis       Date:  2011-09-05       Impact factor: 4.123

4.  Children in clinical trials: survey on the current situation in paediatric university clinics in Germany.

Authors:  Jasmin Khan-Boluki; Ferdinand Hundt
Journal:  Ger Med Sci       Date:  2008-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.